Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Veristat to attend the massbio annual meeting 2016

    1 min read

    Veristat to Attend the MassBio Annual Meeting 2016

    Join Veristat and other Massachusetts life sciences companies at the MassBio Annual Meeting, as they discuss the most critical challenges in bringing new products to market.

    Annual Meeting Highlights Include:

    Keynotes speeches:

    Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate

    Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics

    Remarks from special guests:

    • Charlie Baker, Governor, Commonwealth of Massachusetts
    • Congressman Richard Neal, Dean of the Mass. Delegation
    • Rachel Kaprielian, HHS Regional Director

    Discussion topics to include:

    • The 2016 National Landscape
    • Advanced Manufacturing
    • Innovative Pricing Models: The Future is Now
    • The Future of Finance & Capital Markets
    • An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
    • Digital Healthcare
    • Technology in Clinical Trials
    • The Microbiome
    • Immunotherapy in Combination
    • Biosimilars

    Schedule a Meeting with Veristat

    Take advantage of the time at the event and schedule a time to meet with Veristat.   We are a full-service CRO that can help guide you through the entire clinical development and regulatory process.   Whether you need help writing your protocol, preparing for your regulatory submissions or need a partner to help bring your product from IND to NDA, look to Veristat for a truly collaborative partnership.

    Schedule Meeting_Blue

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...